
Some Good News on Drug Pricing, More to Be Done
Last week’s Consumer Price Index release from the U.S. Bureau of Labor Statistics included some good news on prescription drug
Join Us Live for a Discussion on Medicare, Democracy, and the Future of Health Care

Last week’s Consumer Price Index release from the U.S. Bureau of Labor Statistics included some good news on prescription drug

Last month, U.S. Senator Lisa Blunt Rochester, Senate Finance Committee Ranking Member Ron Wyden, Senate Democratic Leader Chuck Schumer, along

Late last month, the federal government released the first set of data showing enrollment in Affordable Care Act (ACA) plans

Starting in July 2026, some people with Medicare will be eligible for Medicare coverage of certain weight-loss medications through the

This week, the Supreme Court rejected appeals from pharmaceutical companies challenging the Medicare drug price negotiation program established by the

This month, AARP’s Public Policy Institute released a report examining the Medicare Savings Program (MSP)’s asset eligibility limits. The report notes

Earlier this month, CMS released the Final Part C and D Rule for 2027, which revises Medicare Advantage (MA) and

A recent KFF report highlights the impact that the expiration of enhanced premium tax credits as of December 31, 2025

Last week, the Centers for Medicare and Medicaid Services (CMS) announced the selection of the group of 15 drugs for

Last week, the Centers for Medicare & Medicaid Services (CMS) repealed staffing requirements established in a 2024 rule. The rule

Last week’s Consumer Price Index release from the U.S. Bureau of Labor Statistics included some good news on prescription drug

Last month, U.S. Senator Lisa Blunt Rochester, Senate Finance Committee Ranking Member Ron Wyden, Senate Democratic Leader Chuck Schumer, along

Late last month, the federal government released the first set of data showing enrollment in Affordable Care Act (ACA) plans

Starting in July 2026, some people with Medicare will be eligible for Medicare coverage of certain weight-loss medications through the

This week, the Supreme Court rejected appeals from pharmaceutical companies challenging the Medicare drug price negotiation program established by the

This month, AARP’s Public Policy Institute released a report examining the Medicare Savings Program (MSP)’s asset eligibility limits. The report notes

Earlier this month, CMS released the Final Part C and D Rule for 2027, which revises Medicare Advantage (MA) and

A recent KFF report highlights the impact that the expiration of enhanced premium tax credits as of December 31, 2025

Last week, the Centers for Medicare and Medicaid Services (CMS) announced the selection of the group of 15 drugs for

Last week, the Centers for Medicare & Medicaid Services (CMS) repealed staffing requirements established in a 2024 rule. The rule